Fc Receptors in Mast Cell Signaling and Function
肥大细胞信号传导和功能中的 Fc 受体
基本信息
- 批准号:6431716
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Mast cells play a pivotal role in the pathogenesis of asthma and other allergic diseases. These reactions are generally initiated by antigen-dependent aggregation of the high affinity IgE receptor (Fc-epsilon-RI) expressed on the cell surface and subsequent release of pro-inflammatory mediators (e.g. histamine, prostanoids, proteases and cytokines). We have demonstrated that interferon-gamma up-regulates the high affinity receptor for IgG (Fc-gamma-RI) on cultured human mast cells and that aggregation of these receptors leads to mast cell mediator release. An objectof this study is to delineate the signaling pathways of Fc-epsilon-RI and Fc-gamma-RI receptors leading to the release of inflammatory mediators from human mast cells. The current model for the signaling pathway linking Fc-epsilon-RI to mast cell activation has largely been based on studies conducted in RBL 2H3 cells. RBL 2H3 cells are a transformed rodent cell line, which may not be, in all aspects, reflective of the mature human mast cells. The signaling pathways linking the Fc-gamma-RI receptor to mast cell activation have yet to be delineated. It is now possible to grow human mast cells from a CD34-positive, pluripotent cell population in primary culture with sufficient number and purity to study defined signaling events. Thus, we are now examining specific signaling pathways involved in Fc-epsilon-RI- and Fc-gamma-RI- dependent inflammatory mediator release from human mast cells.
肥大细胞在哮喘和其他过敏性疾病的发病机制中起着关键作用。这些反应通常由细胞表面上表达的高亲和力IgE受体(Fc-IgE-RI)的抗原依赖性聚集和随后促炎介质(例如组胺、前列腺素类、蛋白酶和细胞因子)的释放引发。我们已经证明,干扰素-γ上调培养的人肥大细胞上的IgG(Fc-γ-RI)的高亲和力受体,并且这些受体的聚集导致肥大细胞介质释放。本研究的目的之一是阐明Fc-γ-RI和Fc-γ-RI受体导致人肥大细胞释放炎症介质的信号通路。目前将Fc-γ-RI与肥大细胞活化联系起来的信号通路模型主要基于在RBL 2 H3细胞中进行的研究。RBL 2 H3细胞是转化的啮齿类动物细胞系,其在所有方面可能不反映成熟的人肥大细胞。连接Fc-γ-RI受体与肥大细胞活化的信号通路尚未被描述。现在可以在原代培养物中从CD 34阳性多能细胞群中培养人肥大细胞,其数量和纯度足以研究定义的信号传导事件。因此,我们现在正在研究特定的信号通路参与Fc-γ-RI-和Fc-γ-RI-依赖性炎症介质从人肥大细胞释放。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dean D Metcalfe其他文献
Plasma IL-6 correlates with disease category and with hematological parameters in patients with mastocytosis
- DOI:
10.1016/s0091-6749(02)81601-3 - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Knut Brockow;Cem Akin;Mary M Huber;Dean D Metcalfe - 通讯作者:
Dean D Metcalfe
Comparison of FceRI and FcγRI-dependent signaling pathways in human mast cells
- DOI:
10.1016/s0091-6749(02)82259-x - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Christine Tkaczyk;Yoshimishi Okayama;Dean D Metcalfe;Alasdair M Gilfillan - 通讯作者:
Alasdair M Gilfillan
Serum tryptase levels combined with flow cytometric analysis of bone marrow aspirate mast cells differentiate systemic mastocytosis from idiopathic syndromes
- DOI:
10.1016/s0091-6749(02)81675-x - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Cem Akin;Arnold S Kirshenbaum;Dean D Metcalfe - 通讯作者:
Dean D Metcalfe
Direct determination of allergen specific T cell cytokine responses during immunotherapy
- DOI:
10.1016/s0091-6749(02)82225-4 - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
L Brigida Cayosa Hunter;Varatda Plainetr;Barbara Foster;Mary M Huber;Dean D Metcalfe;Calman Prussin - 通讯作者:
Calman Prussin
Dean D Metcalfe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dean D Metcalfe', 18)}}的其他基金
Developmental Immunotherapeutics for Allergic Diseases and Asthma
过敏性疾病和哮喘的发育免疫治疗
- 批准号:
6099081 - 财政年份:
- 资助金额:
-- - 项目类别:
The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders
系统性肥大细胞疾病的发病机制、诊断和治疗
- 批准号:
7964210 - 财政年份:
- 资助金额:
-- - 项目类别:
Activation of Mast Cells in Disease States: Pharmacological Modification
疾病状态下肥大细胞的激活:药理学修饰
- 批准号:
7964545 - 财政年份:
- 资助金额:
-- - 项目类别:
Clinical and Immunological Evaluation of Children with Allergic Disease
儿童过敏性疾病的临床和免疫学评估
- 批准号:
7964522 - 财政年份:
- 资助金额:
-- - 项目类别:
Pediatric Inflammatory Diseases of the Respiratory Tract: Asthma
小儿呼吸道炎症疾病:哮喘
- 批准号:
7732632 - 财政年份:
- 资助金额:
-- - 项目类别:
Molecular Biology Of Mast Cell Growth And Differentiation
肥大细胞生长和分化的分子生物学
- 批准号:
7732464 - 财政年份:
- 资助金额:
-- - 项目类别:
The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders
系统性肥大细胞疾病的发病机制、诊断和治疗
- 批准号:
10014014 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
- 批准号:
23H02361 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : GNT1124162 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : 1124162 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9300976 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9920805 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8900121 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8225814 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8699511 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8525355 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
- 批准号:
9115537 - 财政年份:1991
- 资助金额:
-- - 项目类别:
Standard Grant